Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?
Read More Pharma Industry News Telix wins Pixclara approval as first U.S. FET-PET agent opens brain cancer market Telix has secured FDA approval for Pixclara, the first U.S.-approved FET-PET imaging drug for glioma, converting a 2025 Complete Response Letter into a new brain-cancer diagnostics franchise. byVenkateshSeptember 14, 2026